Risk factors for venous thromboembolism in cancer: Novel findings from the Vienna Cancer and Thrombosis Study (CATS)

Thrombosis Research

Volumn 133, Issue SUPPL. 2, 2014, Pages

  Königsbrügge, Oliver ^a   Pabinger, Ingrid ^a   Ay, Cihan ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Biomarkers; Cancer; Deep vein thrombosis; Pulmonary embolism; Risk assessment; Risk factors; Thromboembolism; Venous thromboembolism

Indexed keywords

BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR 8; D DIMER; PADGEM PROTEIN; THROMBIN;

ARTICLE; CANCER PATIENT; CANCER STAGING; CLINICAL FEATURE; DISEASE ASSOCIATION; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; RISK FACTOR; SUPERFICIAL THROMBOPHLEBITIS; THROMBOCYTE COUNT; THROMBOCYTE VOLUME; VARICOSIS; VEIN DISEASE; VENOUS THROMBOEMBOLISM; BLOOD; MORTALITY; NEOPLASM; PATHOLOGY; PREDICTIVE VALUE;

BIOLOGICAL MARKERS; HUMANS; NEOPLASM STAGING; NEOPLASMS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; VARICOSE VEINS; VENOUS THROMBOEMBOLISM;

EID: 84901452397     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/S0049-3848(14)50007-2     Document Type: Article

References (71)

1. J.F. Timp, S.K. Braekkan, H.H. Versteeg, and S.C. Cannegieter Epidemiology of cancer-associated venous thrombosis Blood 122 2013 1712 1723
2. H.K. Chew, T. Wun, D. Harvey, H. Zhou, and R.H. White Incidence of venous thromboembolism and its effect on survival among patients with common cancers Arch Intern Med 166 2006 458 464
3. S. Sallah, J.Y. Wan, and N.P. Nguyen Venous thrombosis in patients with solid tumors: determination of frequency and characteristics Thromb Haemost 87 2002 575 579 (Pubitemid 34302943)
4. J. Riedl, A. Kaider, E.-M. Reitter, C. Marosi, U. Jäger, and I. Schwarzinger et al. Association of mean platelet volume with risk of venous thromboembolism adn mortality in patients with cancer: results from the Vienna Cancer and Thrombosis Study (CATS) Thromb Haemost 111 2013 670 678
5. D.P. Cronin-Fenton, F. Sondergaard, L.A. Pedersen, J.P. Fryzek, K. Cetin, and J. Acquavella et al. Hospitalisation for venous thromboembolism in cancer patients and the general population: A population-based cohort study in Denmark, 1997-2006 Br J Cancer 103 2010 947 953
6. J.A. Heit, D.N. Mohr, M.D. Silverstein, T.M. Petterson, W.M. O'Fallon, and L.J. Melton Predictors of recurrence after deep vein thrombosis and pulmonary embolism: A population-based cohort study Arch Intern Med 160 2000 761 768 (Pubitemid 30165236)
7. R.A. Douma, M.G. Kok, L.M. Verberne, P.W. Kamphuisen, and H.R. Büller Incidental venous thromboembolism in cancer patients: prevalence and consequence Thromb Res 125 2010 e306 e309
8. T. Gary, K. Belaj, K. Steidl, M. Pichler, F. Eisner, and H. Stöger et al. Asymptomatic deep vein thrombosis and superficial vein thrombosis in ambulatory cancer patients: impact on short-term survival Br J Cancer 107 2012 1244 1248
9. G.C. Connolly, L. Menapace, S. Safadjou, C.W. Francis, and A.A. Khorana Prevalence and clinical significance of incidental and clinically suspected venous thromboembolism in lung cancer patients Clin Lung Cancer 14 2013 713 718
10. A. Khorana, C.W. Francis, E. Culakova, N.M. Kuderer, and G.H. Lyman Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy J Thromb Haemost 5 2007 632 634 (Pubitemid 46680709)
11. M. Monreal, C. Falgá, M. Valdés, C. Suárez, F. Gabriel, and C. Tolosa et al. Fatal pulmonary embolism and fatal bleeding in cancer patients with venous thromboembolism: findings from the RIETE registry J Thromb Haemost 4 2006 1950 1956
12. H. Sørensen, and L. Mellemkjær Prognosis of cancers associated with venous thromboembolism N Engl J Med 343 2000 1846 1850 (Pubitemid 32104130)
13. P. Prandoni, A.W. Lensing, A. Piccioli, E. Bernardi, P. Simioni, and B. Girolami et al. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis Blood 100 2002 3484 3488 (Pubitemid 35303914)
14. A.A. Khorana, N.M. Kuderer, E. Culakova, G.H. Lyman, and C.W. Francis Development and validation of a predictive model for chemotherapy-associated thrombosis Blood 111 2008 4902 4907
15. C. Ay, D. Dunkler, C. Marosi, A.-L. Chiriac, R. Vormittag, and R. Simanek et al. Prediction of venous thromboembolism in cancer patients Blood 116 2010 5377 5382
16. T. Wun, and R.H. White Epidemiology of cancer-related venous thromboembolism Best Pr Res Clin Haematol 22 2009 9 23
17. J. Blom, and C. Doggen Malignancies, prothrombotic mutations, and the risk of venous thrombosis JAMA 293 2005 715 722 (Pubitemid 40216041)
18. V.Q. Trinh, P.I. Karakiewicz, J. Sammon, M. Sun, S. Sukumar, and M.-K. Gervais et al. Venous Thromboembolism After Major Cancer Surgery: Temporal Trends and Patterns of Care JAMA Surg 02115 2013 1 7
19. K. Kröger, D. Weiland, C. Ose, N. Neumann, S. Weiss, and C. Hirsch et al. Risk factors for venous thromboembolic events in cancer patients Ann Oncol 17 2006 297 303 (Pubitemid 43160121)
20. S.V. Rajkumar, E. Blood, D. Vesole, R. Fonseca, and P.R. Greipp Phase III clinical trial of thalidomide plus dexamethasone compared with dexamethasone alone in newly diagnosed multiple myeloma: A clinical trial coordinated by the Eastern Cooperative Oncology Group J Clin Oncol 24 2006 431 436 (Pubitemid 46630462)
21. S.V. Rajkumar, S.R. Hayman, M.Q. Lacy, A. Dispenzieri, S.M. Geyer, and B. Kabat et al. Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma Blood 106 2005 4050 4053 (Pubitemid 41775908)
22. F.A. Scappaticci, J.R. Skillings, S.N. Holden, H.-P. Gerber, K. Miller, and F. Kabbinavar et al. Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab J Natl Cancer Inst 99 2007 1232 1239 (Pubitemid 47299901)
23. M. Mandala, M. Clerici, I. Corradino, C. Vitalini, S. Colombini, and V. Torri et al. Incidence, risk factors and clinical implications of venous thromboembolism in cancer patients treated within the context of phase I studies: the "SENDO experience" Ann Oncol 23 2012 1416 1421
24. M. Tesselaar, J. Ouwererk, M. Nooy, F.R. Rosendaal, and S. Osanto Risk factors for catheter-related thrombosis in cancer patients Eur J Cancer 40 2004 2253 2259 (Pubitemid 39348875)
25. J. Bohlius, K. Schmidlin, C. Brillant, G. Schwarzer, S. Trelle, and J. Seidenfeld et al. Erythropoietin or darbepoetin for patients with cancer - meta- analysis based on individual patient data Cochrane Database Syst Rev 3 2009 CD007303
26. T. Barbui, G. Finazzi, A. Grassi, and R. Marchioli Thrombosis in cancer patients treated with hematopoietic growth factors - a meta analysis. On behalf of the Subcommittee on Haemostasis and Malignancy of the Scientific and Stadardization Committee of ISTH Thromb Haemost 75 1996 368 371
27. A.A. Khorana, C.W. Francis, E. Culakova, N.M. Kuderer, and G.H. Lyman Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients Cancer 110 2007 2339 2346 (Pubitemid 350100757)
28. I. Pabinger, and C. Ay Risk of venous thromboembolism and primary prophylaxis in cancer. Should all patients receive thromboprophylaxis? Hamostaseologie 32 2012 132 137
29. G. Numico, O. Garrone, V. Dongiovanni, N. Silvestris, I. Colantonio, and G. Di Costanzo et al. Prospective evaluation of major vascular events in patients with nonsmall cell lung carcinoma treated with cisplatin and gemcitabine Cancer 103 2005 994 999 (Pubitemid 40270076)
30. B. Dickmann, J. Ahlbrecht, C. Ay, D. Dunkler, J. Thaler, and W. Scheithauer et al. Regional lymph node metastases are a strong risk factor for venous thromboembolism: results from the Vienna Cancer and Thrombosis Study Haematologica 98 2013 1309 1314
31. G. Agnelli, G. Bolis, L. Capussotti, R.M. Scarpa, F. Tonelli, and E. Bonizzoni et al. A Clinical Outcome-Based Prospective Study on Venous Thromboembolism After Cancer Surgery Ann Surg 243 2006 89 95 (Pubitemid 43054059)
32. A. Alcalay, T. Wun, V. Khatri, H.K. Chew, D. Harvey, and H. Zhou et al. Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival J Clin Oncol 24 2006 1112 1118 (Pubitemid 46638808)
33. A.O. Rodriguez, T. Wun, H. Chew, H. Zhou, D. Harvey, and R.H. White Venous thromboembolism in ovarian cancer Gynecol Oncol 105 2007 784 790 (Pubitemid 46734211)
34. H.K. Chew, T. Wun, D.J. Harvey, H. Zhou, and R.H. White Incidence of venous thromboembolism and the impact on survival in breast cancer patients J Clin Oncol 25 2007 70 76 (Pubitemid 350003053)
35. H.K. Chew, A.M. Davies, T. Wun, D. Harvey, H. Zhou, and R.H. White The incidence of venous thromboembolism among patients with primary lung cancer J Thromb Haemost 6 2008 601 608 (Pubitemid 351404927)
36. R. Sandhu, C.-X. Pan, T. Wun, D. Harvey, H. Zhou, and R.H. White et al. The incidence of venous thromboembolism and its effect on survival among patients with primary bladder cancer Cancer 116 2010 2596 2603
37. J.W. Blom, S. Osanto, and F.R. Rosendaal High risk of venous thrombosis in patients with pancreatic cancer: A cohort study of 202 patients Eur J Cancer 42 2006 410 414 (Pubitemid 43132898)
38. J. Ahlbrecht, B. Dickmann, C. Ay, D. Dunkler, J. Thaler, and M. Schmidinger et al. Tumor grade is associated with venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study J Clin Oncol 30 2012 3870 3875
39. S. Tateo, L. Mereu, S. Salamano, C. Klersy, M. Barone, and A.C. Spyropoulos et al. Ovarian cancer and venous thromboembolic risk Gynecol Oncol 99 2005 119 125 (Pubitemid 41354592)
40. W. Ageno, A. Squizzato, D. Garcia, and D. Imberti Epidemiology and Risk Factors of Venous Thromboembolism 1 2006 651 658
41. M. Samama An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study Arch Intern Med 160 2000 3415 3420
42. G. Srkalovic, M.G. Cameron, L. Rybicki, S.R. Deitcher, K. Kattke-Marchant, and M.A. Hussein Monoclonal gammopathy of undetermined significance and multiple myeloma are associated with an increased incidence of venothromboembolic disease Cancer 101 2004 558 566 (Pubitemid 38970607)
43. C. Ay, D. Dunkler, R. Simanek, J. Thaler, S. Koder, and C. Marosi et al. Prediction of venous thromboembolism in patients with cancer by measuring thrombin generation: results from the Vienna Cancer and Thrombosis Study J Clin Oncol 29 2011 2099 2103
44. R. Vormittag, R. Simanek, C. Ay, D. Dunkler, P. Quehenberger, and C. Marosi et al. High factor VIII levels independently predict venous thromboembolism in cancer patients: the cancer and thrombosis study Arterioscler Thromb Vasc Biol 29 2009 2176 2181
45. C. Ay, R. Simanek, R. Vormittag, D. Dunkler, G. Alguel, and S. Koder et al. High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS) Blood 112 2008 2703 2708
46. R. Simanek, R. Vormittag, C. Ay, G. Alguel, D. Dunkler, and I. Schwarzinger et al. High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS) J Thromb Haemost 8 2010 114 120
47. R. Kanz, T. Vukovich, R. Vormittag, D. Dunkler, C. Ay, and J. Thaler et al. Thrombosis risk and survival in cancer patients with elevated C-reactive protein J Thromb Haemost 9 2011 57 63
48. P. Prandoni, E. Casiglia, V. Tikhonoff, A. Leizorovicz, and H. Decousus The risk of subsequent cancer and arterial cardiovascular events in patients with superficial vein thrombosis in the legs Blood 118 2011 4719 4722
49. F.F. Van Doormaal, S. Atalay, H.J. Brouwer, E.F. Van Der Velde, H.R. Buller, and H.C. Van Weert Idiopathic superficial thrombophlebitis and the incidence of cancer in primary care patients Ann Fam Med 47 2010 50
50. R.E.J. Roach, W.M. Lijfering, Vlieg A. Van Hylckama, F.M. Helmerhorst, F.R. Rosendaal, and S.C. Cannegieter The risk of venous thrombosis in individuals with a history of superficial vein thrombosis and acquired venous thrombotic risk factors Blood 122 2013 4264 4269
51. O. Königsbrügge, F. Lötsch, E.-M. Reitter, T. Brodowicz, C. Zielinski, and I. Pabinger et al. Presence of varicose veins in cancer patients increases the risk for occurrence of venous thromboembolism J Thromb Haemost 11 2013 1993 2000
52. C. Ay, R. Vormittag, D. Dunkler, R. Simanek, A.-L. Chiriac, and J. Drach et al. D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study J Clin Oncol 27 2009 4124 4129
53. S.K. Braekkan, E.B. Mathiesen, I. Njølstad, T. Wilsgaard, J. Størmer, and J.B. Hansen Mean platelet volume is a risk factor for venous thromboembolism: the Tromsø Study, Tromsø, Norway J Thromb Haemost 8 2010 157 162
54. G. Slavka, T. Perkmann, H. Haslacher, S. Greisenegger, C. Marsik, and O.F. Wagner et al. Mean platelet volume may represent a predictive parameter for overall vascular mortality and ischemic heart disease Arterioscler Thromb Vasc Biol 31 2011 1215 1218
55. M. Lishner, A. Leader, and D. Pereg Are platelet volume indices of clinical use? A multidisciplinary review Ann Med 1 2012 1 12
56. H. Giles, R.E. Smith, and J.F. Martin Platelet glycoprotein IIb-IIIa and size are increased in acute myocardial infarction Eur J Clin Invest 24 1994 69 72 (Pubitemid 24204957)
57. J.E. Geddings, and N. Mackman Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients Blood 122 2013 1873 1880
58. A. Bhartuar, A.A. Khorana, A. Hutson, J.-G. Wang, N.S. Key, and N. Mackman et al. Circulating microparticle tissue factor, thromboembolsim and survival in pancreaticobiliary cancers Thromb Res 132 2013 180 184
59. D. Manly, J. Wang, and S. Glover Increased microparticle tissue factor activity in cancer patients with venous thromboembolism Thromb Res 125 2010 511 512
60. G. Hron, M. Kollars, H. Weber, V. Sagaster, P. Quehenberger, and S. Eichinger et al. Tissue factor-positive microparticles: Cellular origin and association with coagulation activation in patients with colorectal cancer 2007 119 123
61. M.E. Tesselaar, F.P. Romijn, I.K. Van Der Linden, R.M. Bertina, and S. Osanto Microparticle-associated tissue factor activity in cancer patients with and without thrombosis J Thromb Haemost 7 2009 1421 1423
62. R.S. Kasthuri, M.B. Taubman, and N. Mackman Role of tissue factor in cancer J Clin Oncol 27 2009 4834 4838
63. Y.W. Van den Berg, S. Osanto, P.H. Reitsma, and H.H. Versteeg The relationship between tissue factor and cancer progression: insights from bench and bedside Blood 119 2012 924 932
64. A. Khorana, and C. Francis Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer J Thromb Haemost 6 2008 1983 1985
65. J. Thaler, C. Ay, N. Mackman, R.M. Bertina, A. Kaider, and C. Marosi et al. Microparticle-associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients J Thromb Haemost 10 2012 1363 1370
66. J. Thaler, C. Ay, N. Mackman, S. Metz-Schimmerl, J. Stift, and A. Kaider et al. Microparticle-associated tissue factor activity in patients with pancreatic cancer: correlation with clinicopathological features Eur J Clin Invest 43 2013 277 285
67. F. Rickles, S. Patierno, and P. Fernandez Tissue factor, thrombin, and cancer Chest 124 2003 58S 68S (Pubitemid 37128437)
68. J.L. Yu, L. May, V. Lhotak, S. Shahrzad, S. Shirasawa, and J.I. Weitz et al. Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis Blood 105 2005 1734 1741 (Pubitemid 40223697)
69. A. Kakkar, N. Lemoine, M. Scully, S. Tebbutt, and R. Williamson Tissue factor expression correlates with histological grade in human pancreatic cancer Br J Surg 82 1995 1101 1104
70. S. Seto, H. Onodera, T. Kaido, A. Yoshikawa, S. Ishigami, and S. Arii et al. Tissue factor expression in human colorectal carcinoma: Correlation with hepatic metastasis and impact on prognosis Cancer 88 2000 295 301 (Pubitemid 30051812)
71. J. Thaler, M. Preusser, C. Ay, A. Kaider, C. Marosi, and C. Zielinski et al. Intratumoral tissue factor expression and risk of venous thromboembolism in brain tumor patients Thromb Res 131 2013 162 165